AAPP Scientific Poster Session Abstracts

Browse abstracts for all scientific posters that have been presented at the AAPP Annual Meeting.

Use the search box to quickly locate an abstract by any data in the column, including "PGY2"! The site search provides full-text search of all abstracts that have been presented at the AAPP Annual Meeting over the years.

Browse: 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025

Currently Viewing Abstracts from 2025

Title
5-HT2C Receptors Contribute to Viloxazine’s Effects on ADHD-relevant Behaviors in Rats on the 5-Choice Serial Reaction Time Task
A Convergent, Parallel, Mixed Methods Study to Identify Barriers to Access to Mental Health Care in the Haitian Population of a Midwestern Academic Medical Center
A Prescription Digital Therapeutic, CT-152, for Treating Major Depressive Disorder: Effectiveness and Safety Results of the MIRAI Randomized Controlled Trial
A Randomized, Open Label, Multiple-dose, Two-way Study to Evaluate Bioavailability of Clonidine HCl Extended-release Oral Suspension compared to Clonidine HCl Extended-release Tablets
A Retrospective Comparison of Initiation with Intramuscular Paliperidone Palmitate LAI and Subcutaneous Risperidone LAI on 30-day Readmission Rates in a Behavioral Health Inpatient Treatment Facility
A Retrospective Evaluation of Benzodiazepine Tapering Practices and Outcomes in Veterans Following Chronic Use at a Level 1A Federal Healthcare System
A Retrospective Review of As-Needed Medications and Their Role in Predicting Aggression in Forensic Psychiatric Patients
A Review of the Delivery Technologies used in Attention-Deficit/Hyperactivity Disorder Stimulant Medications
Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From an Additional Randomized, Double-Blind, Phase 3 Trial
Advancing Schizophrenia Treatment: A Modified Delphi Consensus on The Critical Role of Psychiatric Pharmacists in Prescription Digital Therapeutics
Alternative Modes of Administration for Once-Daily Valbenazine to Treat Tardive Dyskinesia or Chorea Associated With Huntington’s Disease in Patients Experiencing Dysphagia
An Evaluation of Buprenorphine Transition Strategies in a Pharmacist-Led Chronic Pain Clinic
Analysis of Correlation Between Total Anticholinergic Load and As-Needed Medication Administrations in an Inpatient Psychiatric Hospital
Antimicrobial Exposure and Risk for Major Depressive Disorder Recurrence
Antipsychotic Prescribing Patterns in Dual Diagnosis Patients on ED Discharge
Appropriateness of Antipsychotic Long Acting Injectable (LAI) Prescribing, Monitoring, and Administration at VA Northern California Health Care System (VANCHCS)
Aripiprazole Levels After Inadvertent Administration of Aripiprazole lauroxil 1064 mg in the Deltoid Muscle: a case report
Aripiprazole, A Partial Dopamine Agonist Antipsychotic, and Its Effects on Psychosis When Used Concomitantly with Full Dopamine Antagonist Antipsychotics
As-Needed Medication Use for Agitation and Psychosis Across Valproic Acid Formulations
Assessing the Impact of Naloxone Training for Students, Faculty, and Staff within a School of Pharmacy
Assessing the Impact of Patient Health Questionnaire-9 and General Anxiety Disorder-7 Monitoring in Outpatient Depression and Anxiety
Assessing the Pharmacist's Role in Harm Reduction via Clinical Exposure
Attitudes Towards Pharmacy Amongst Those That Actively Inject Drugs
Atypical Antipsychotic Associated Weight Gain for Autism Spectrum Disorder Irritability
Awareness and Perceptions of Fentanyl Criminalization Policies: A Survey Report
Barriers to Utilization of Clozapine versus Antipsychotic Polypharmacy in a State Hospital System
Budget Impact analysis of Xanomeline and Trospium Chloride for the Treatment of Adults with Schizophrenia in the US
Buspirone Use Evaluation at an Inpatient Psychiatric Hospital
Characterization of Medications Prescribed for Agitation in a Psychiatric ICU
Clinical Outcomes of Long-Acting Injectables in People Experiencing Homelessness
Clozapine Continuity: The Key to Stability Amid Command Hallucinations and Detrimental Self-Injury
Clozapine-Induced Eosinopenia in Patients with Treatment-Resistant Schizophrenia: Case Series and Literature Review
Cobalamin Conundrum: How low can B12 go?
Commercially Insured Patient Profiles and Risk Factors Attributing to Non-Adherence Amongst Opioid Use Disorder Patients (OUD) Treated with Monthly Injectable Buprenorphine: A Retrospective Claims Analysis
Community Pharmacy-Based Long-Acting Injectable (LAI) Service Reimbursement
Comparison of High-Dose Olanzapine and Standard-Dose Olanzapine in Adult Patients at a County Psychiatric Hospital (A Continuation Study)
Compatibility of Administering Long-Acting Injectable Antipsychotics in Community Pharmacies across Washington State
Continuing Professional Development Self-Reporting by Board-Certified Psychiatric Pharmacists
CT-152, a Prescription Digital Therapeutic for Major Depressive Disorder: A Real-World Analysis of Durability of Treatment Effect
Describing Intravenous Ketamine Response for Treatment-Resistant Depression or Major Depressive Disorder with Suicidal Ideation in Intranasal Esketamine Non-Responders
Determining the Average Anticholinergic Burden in Inpatient Psychiatric Patients Across Various Age Groups
Development of a Pharmacist-Led Pediatric Long-Acting Injectable Antipsychotic (LAI-A) Treatment Program
Development of a Scoring Tool to Identify High-Risk Discharges in Psychiatric Transitions of Care
Early Improvement of Symptoms in Bipolar I Depression Predicts Functional Response and Recovery: A Post Hoc Analysis
Education on Proper Administration of Transmucosal Buprenorphine to Improve Dental Adverse Outcomes in Patients with OUD
Effect of Antipsychotic Initiation on Psychotic Symptoms in Patients Using Stimulants: A Retrospective Chart Review
Effectiveness of Pharm.D.-Integrated Mental Health Courses for Improving Perceptions of Mental Health Conditions Among Pharmacy Students
Effects of Injectable Calcitonin Gene Related Peptide-Antagonists on Migraine-Associated Cost Burden
Efficacy and Safety of Esketamine Nasal Spray as Monotherapy in Adult Patients with Treatment-Resistant Depression for up to 4-Months of Treatment: A Post Hoc Analysis
Efficacy of Mirtazapine Versus Clonidine for Resistant PTSD Nightmares in Veterans: An Observational Study
Enhancing Clinical Vigilance: Utilizing the Simpson-Angus Scale in Provider Trainings for Detection of Parkinsonian Symptoms in Antipsychotic Treatment in Outpatient Mental Health Settings
Enhancing Naloxone Distribution and Education to At-Risk Veterans Through Utilization of AudioCARE Technology
Establishing and Evaluating a Clinical Pharmacist’s Role in an Outpatient Geropsychiatry Clinic
Evaluating A Pharmacist Driven Clozapine Best Practices Standardization in Inpatient Psychiatry Units
Evaluating Concurrent Benzodiazepine and Opioid Use after an Educational Intervention in Eligible Veterans at a Veterans Affair Outpatient Health Care System
Evaluating the Administration of One-time Order Intramuscular Antipsychotics Amongst Different Racial Groups Within Adult Inpatient Psychiatric Units
Evaluating the Effectiveness and Safety of Cariprazine on Inpatient Psychiatry: A Medication Use Review
Evaluating the Effects of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on Substance Use Disorders
Evaluating the Perceived Value of Psychiatric Clinical Pharmacist Specialist Services
Evaluating the Transition from Full Agonist Opioid to Buprenorphine for Management of Veterans on Long Term Opioid Therapy for Chronic Pain
Evaluating the Understandability, Actionability, Quality, and Readability of AI-Generated Health Information on Eating Disorders: A Comparative Analysis of ChatGPT Free and Pro Versions
Evaluating the Use of Sexually Transmitted Infection Testing in a Psychiatric Hospital
Evaluating the Utility of a Retrospective, Pharmacy-Initiated Medication Reconciliation Process
Evaluation and Optimization of Medication Management to Prevent Restraint Episodes in Adult Patients Admitted to an Inpatient Psychiatric Facility
Evaluation and Reduction of Pill Burden in the Inpatient Psychiatric Setting
Evaluation of Midazolam Efficacy as an Alternative for Lorazepam for Management of Acute Agitation in Behavioral Health Patients
Evaluation of Naloxone Kits Prescribed to Patients Diagnosed With Stimulant Use Disorder
Evaluation of Paliperidone Palmitate Loading Doses in Adult Patients with Reduced versus Normal Renal Function at a Stand-Alone Psychiatric Hospital
Evaluation of Patient Outcomes Associated with Administration of Long-Acting Injectable Antipsychotics in the Inpatient Psychiatric Setting
Evaluation of Pharmacy Means Reduction for Veterans Enrolled in the High Risk for Suicide Program
Evaluation of Psychiatric Pharmacists’ Perspectives of Medical and Recreational Cannabis
Evaluation of the Appropriateness of Haloperidol Decanoate Dosing in Inpatients with Serious Mental Illness
Evaluation of the Distribution of Naloxone Kits in Patients Diagnosed with Opioid Use Disorder
Evaluation of the Feasibility and Potential Impact of Providing Ambulatory Alcohol Withdrawal Management Within A VA Medical Center
Evaluation of the Utilization of Pharmacological Treatment for Alcohol Use Disorder in an At-Risk Outpatient Veteran Population
Evaluation of Therapeutic Indication and Utilization of Lamotrigine in an Inpatient Psychiatric Hospital
Exploring Mental Health Service Utilization and Challenges Among Graduate Students in Healthcare Programs: A Cross-Sectional Study
Factors Associated With Delta-8 Tetrahydrocannabinol Admission To A Behavioral Health Hospital
Factors Influencing Hospital Length of Stay in Patients Receiving New Lithium Therapy for Acute Bipolar Illness at an Inpatient Psychiatric Facility
Identification and Assessment of Mental Health-Related Stigma in Relation to Mental Health Diagnosis and Medication Use Among College Students
Impact of a Board-Certified Psychiatric Pharmacist Integrated into a Team-Based Outpatient Psychiatry Clinic
Impact of a Mental Health Clinical Pharmacist Practitioner on Patient Outcomes at a Veterans Substance Abuse Treatment Team Clinic
Impact of a Pharmacy Mental Health Practitioner on an Inpatient Psychiatry Consultation Liaison Service
Impact of a Text Message Intervention on Naloxone Prescriptions for Individuals with Stimulant Use Disorder
Impact of Ambulatory Care Psychiatry Pharmacist Medication Reviews and Histories
Impact of Esketamine Therapy Discontinuation on Depression Stability in Veterans with Treatment Resistant Depression
Impact of Inpatient Pharmacist-Led Metabolic Monitoring in Patients Administered Antipsychotics
Impact of Patient Demographics on Prescribing Practices on an Inpatient Child and Adolescent Psychiatric Unit
Impact of Patient Variables and Time of Day on Clozapine Serum Concentrations Using a Novel Immunoassay Platform
Impact of Pharmacist Clinical Monitoring of Lithium in an Inpatient Psychiatric Setting
Impact of Psychiatry Advanced Pharmacy Practice Experience on Student Pharmacist Apprehensions Towards Psychiatry
Impact of Social Determinants of Health on Escalation to Antipsychotic Polypharmacy in Outpatient Mental Health Clinics
Impact of the Integration of a Clinical Pharmacy Specialist into a Ketamine Infusion Clinic for Treatment-Resistant Depression
Implementation and Evaluation of Pharmacist-Led Pharmacogenomic Testing for Antidepressant Therapy in Patients with Treatment Resistant Depression at a Single-Center Veteran Affairs Hospital
Implementation of a Pharmacist Led Clinic in Outpatient Mental Health
Implementation of a Syringe Services Program (SSP) at a Rural Veterans Affairs Medical Center and Outpatient Clinics: A Harm Reduction Project
Implementing Esketamine: A Pilot Study for Enhancing Treatment-Resistant Depression Care in a Health System
Improving Access to Naloxone for Patients with Stimulant Use Disorder
Improving Laboratory Monitoring Compliance in Patients Prescribed Antipsychotics, Lithium, or Divalproex Sodium with Pharmacist-Led Intervention
Improving SUD Harm Reduction Efforts in Community Pharmacies via an Asynchronous Education Program
Increasing Access to Pharmacogenomics Testing to Veterans with Mental Health Disorders
Integration of a Psychiatric Pharmacist into a Pediatric Psychiatric Emergency Department and Novel Outpatient Crisis Clinic
Integration of Mental Health Clinical Pharmacist Practitioner into Inpatient Substance Use Disorder Consult Team to Expand Substance Use Disorder Pharmacotherapy Initiation for Hospitalized Patients
Investigating the trends in novel designer drug use in Los Angeles County from 2020-2023
Long-term Dexamethasone in the Treatment of Secondary Epilepsy due to Grade 4 Astrocytoma IDH Mutant
Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: Results from the 52-Week, Open-Label EMERGENT-4 Trial
Long-Term Safety, Tolerability, and Efficacy of Xanomeline and Trospium Chloride in People With Schizophrenia: Results From the 52-Week, Open-Label EMERGENT-5 Trial
Louisiana Community Pharmacist Knowledge and Attitudes Toward Medication-Assisted Treatment (MAT) for Opioid Use Disorder: A Qualitative Study
Low-Dose Glucagon-Like Peptide-1 Receptor Agonists to Reverse Antipsychotic-Induced Weight Gain in Patients with Type 2 Diabetes Mellitus
Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial
Medication Adherence Following Pharmacogenomic Testing in Insurance Claims Data from Patients with Major Depressive Disorder
Medication Superhero Group on an Inpatient Child Psychiatry Unit
Monitoring Pharmacogenomic Interventions in the Mental Health Setting at a Veterans Affairs Hospital
Nonprescription Syringe and Over-the-Counter Naloxone Availability in Community Pharmacies: A Secret Shopper Purchase Audit in Austin, TX
Not just a weight loss drug-Exploring the Potential of GLP-1 Receptor Agonists in Treating Substance Use Disorders
Opioid Use Disorder Medicaid Patient Profiles and Risk Factors Contributing to Non-Adherence to Monthly Injectable Buprenorphine: Retrospective Claims Analysis
Optimizing Management of Opioid-Induced Constipation at a Single Veterans Affairs Medical Center
Optimizing Medication Services for the Unhoused in a Street Psychiatry Clinic
Optimizing Pharmacotherapy for Suicidal Ideation: An Evaluation of Appropriate Initiation Strategies at a Large Non-Profit Hospital
Outcomes of a Pharmacist-Led Benzodiazepine Taper Clinic
Outcomes Related to Psychiatric Pharmacist Care of Patients with Mental Illness
Outpatient Long-Acting Injectable Antipsychotic Clinic in a Safety Net Hospital
Patient and Environmental Factors Affecting Sublingual Buprenorphine Prescription Pick-up
Patient Characteristics Associated with Medication Selection for Acute Agitation in a Behavioral Health Emergency Department
Patients and Providers Satisfaction Surveys on Long-Acting Injection Antipsychotics
Patients' Preferences Towards Antipsychotic Induced Weight Gain Management
Patterns of Pharmacologic Treatment for the Inpatient Management of Acute Bipolar Depression
Perceptions of Psychiatric Care Amongst Formerly Incarcerated Individuals
Pharmacist-Led Education and Training of Health Care Practitioners to Administer Long-Acting Injectable Medications
Pharmacist-led Implementation of Extended-release Buprenorphine in an Inpatient General Psychiatry Unit
Pharmacist-Led Psychotropic Stewardship Program to Assess Antipsychotic Polypharmacy
Pharmacy-Led Medication Reconciliation at an Inpatient Behavioral Health Facility
Phenobarbital Versus Benzodiazepine for Alcohol Withdrawal in General Medicine Setting: Focus on Safety and Hospital Length of Stay
Postoperative Buprenorphine Management in Patients Taking Buprenorphine Prior to Admission
Potential Inpatient Cost-Savings Using Subcutaneous Risperidone ER Versus Paliperidone Palmitate Based on Prescribing Trends of Oral Risperidone
Prevalence of ADHD in People Who Use Methamphetamine
Provider Perspectives on Low-Dose Initiation Strategies for Buprenorphine
Psilocybin for Treatment Resistant Depression: Exploring Potential Mechanisms of Action and Addressing Unblinding in Randomized Control Trials
Psychedelic-Assisted Therapy for PTSD and Depression: a review of the literature
Psychiatric Electives in United States Colleges of Pharmacy: A Narrative Review
Psychiatric Pharmacist consultation orders in a Pediatric Mental Health Institute
Psychiatric Pharmacist Impact on Long-Acting Injectable Antipsychotic Utilization
Psycho-Oncology and the Use of Psychotropics for the Management of Chemobrain Symptoms: A Review of the Literature
Quality, Readability, Accessibility, and Understandability of Chat GPT-Generated Information for Alzheimer's Disease
Quantifying Nonprescription Syringe Access in Oregon: A County-Level Perspective
Recurrent Clozapine Induced Pneumonia 
Reimplementation of a Pharmacist-Centered Contingency Management Service – Current Challenges and Expansions to the Program
Relationship Between Patient-specific Factors and Clozapine Prescribing During Psychiatric Hospitalization
Retrospective Review of Hospital Length of Stay in Patients Receiving As-Needed Olanzapine After Implementation of As Needed (PRN) Agitation Order Set
Retrospective Study of Neuropsychiatric Hospitalizations in Patients Receiving Montelukast vs. Loratadine for Allergic Rhinitis in a Veterans Affairs Population
Safety and Tolerability of Lumateperone 42 mg for the Adjunctive Treatment of Major Depressive Disorder: A Pooled Analysis of 2 Randomized Placebo-Controlled Trials
Serotonin Syndrome and Protracted Discontinuation Syndrome with Escitalopram in a CYP2C19 Poor Metabolizer – A case report
Somatic Symptom Disorder: Role of the Pharmacist in Minimizing Polypharmacy
Strengthening the Behavioral and Mental Health Workforce Through Pharmacy Education
Study Retention Rates in the Olanzapine/Samidorphan Phase 3 Clinical Program
Sublingual Dexmedetomidine versus Standard of Care for Agitation within an Inpatient Psychiatric Facility
Substantial Long-Term Improvements With Valbenazine 40 mg in Adults with Tardive Dyskinesia
Survey of Local Patterns of Fentanyl Exposure and Assessment of Harm Reduction Strategies
Systematic Review of Montelukast’s Potential for Drug Repurposing and Management of Neurodegenerative Disorders
Texas Community Pharmacists’ Knowledge, Perceptions, and Practices Related to Dispensing Buprenorphine for Opioid Use Disorder: A Cross-Sectional Online Survey
The Association Between Mental Health Disorders and Allergic Reactions: A Multicenter Retrospective Analysis
The Effect of Subcutaneous Risperidone Long-Acting Injectable on 30-Day Readmission Rates in Adult and Adolescent Patients at a Safety-Net Psychiatric Hospital: a Retrospective Review
The Impact of a Modified Clozapine Titration Protocol on the Rates of Diagnosed Clozapine-Induced Myocarditis for Newly Initiated Patients Admitted to a Stand-Alone Psychiatric Hospital
The Impact of Antipsychotics in the Treatment of Catatonia
The impact of initiating pharmacotherapy for alcohol use disorder in the inpatient medical unit on hospital readmission rates for alcohol withdrawal at a Federal Health Care Center
The Impact of Pharmacogenomic Testing on Antidepressant Therapy at a VA Medical Center
The Occurrence of Mental Health Diagnoses in GLP-1 Receptor Agonist Treated Patients
The Pharmacist's Role in Clozapine Initiation: Early Detection of Clozapine-Induced Myocarditis – A Case Report
The Role of the Psychiatric Pharmacist in Shared Medical Appointments for Individuals with Bipolar Disorder
Therapeutic Use of Cannabidiol (CBD) in Autism Spectrum Disorder: A Comprehensive Review of Mechanisms of Action and Clinical Applications
Tirzepatide-The first and only prescription medicine for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity: A Scoping Review
Transitioning Patients to Longer Duration Long-Acting-Injectable Antipsychotics at a Certified Community Behavioral Health Clinic
Treatment Patterns and Healthcare Resource Utilization of Patients With Schizophrenia Prescribed Aripiprazole Lauroxil Versus Oral Aripiprazole: A Retrospective Claims-Based Study
Use of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) on Alcohol Use Disorder and Opioid Use Disorder Healthcare Related Outcomes
Use of Hypnotic Agents for Pediatric/Adolescent Patients in an Inpatient Behavioral Health Facility
Use of Vilazodone for the Treatment of Posttraumatic Stress Disorder
Utilizing Pharmacist Roles to Improve the Use of Medication Assisted Therapy for Alcohol Use Disorder on an Internal Medicine Floor at a VA Institution
Utilizing Pharmacogenomic Testing Among Primary Care Providers to Guide Initial Antidepressant Therapy Selection
Utilizing Vaccine Outreach to Assess Day Center Client Mental Health: A Single-Center, Prospective Study
Viloxazine Extended-release Capsules Meaningfully Improved Executive Function in Adult ADHD: Post-Hoc Analyses of Phase III Double-Blind and Open-Label Extension Trials
Weight loss was more common than weight gain in Adults treated with Viloxazine ER for Attention-Deficit/Hyperactivity Disorder in short and long-term phase 3 clinical trials